Page last updated: 2024-08-17

uridine triphosphate and Carcinoma, Pancreatic Ductal

uridine triphosphate has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JH; Ji, YG; Lee, DH	1

Other Studies

1 other study(ies) available for uridine triphosphate and Carcinoma, Pancreatic Ductal

Article	Year
Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor. Pancreas, 2013, Volume: 42, Issue:4 Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y2; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Uridine Triphosphate	2013

Article

Year

Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.

Pancreas, 2013, Volume: 42, Issue:4

Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Epithelial Cells; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y2; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Uridine Triphosphate

2013